TEM Q2 2026 - Preliminary Earnings Alert
Event: Quartr Q2 2026 event Retrieved: 2026-07-30T20:05:00Z Source status: Earnings release and quarterly report are available; transcript is not yet available.
Beat/Miss
Beat/miss unavailable - API Ninjas definition or period mismatch. API Ninjas supplied a July 30 estimate of $379.7 million revenue and $(0.143) EPS, but did not supply the fiscal-period, period-type, currency, revenue-definition, or EPS-basis metadata needed for a permitted match. No provider actuals or provider-calculated differences were used.
Reported results and guidance
- Q2 revenue was $382.5 million, up 22% year over year.
- GAAP net income was $5.6 million ($0.03 basic EPS); adjusted EBITDA was $8.0 million.
- Diagnostics revenue was $289.3 million, while Data and Applications revenue was $93.2 million; Oncology volume grew 31%.
- 2026 revenue guidance increased to $1.595-$1.605 billion and adjusted EBITDA guidance remains about $65 million.
Management points
- Management attributed growth to the Oncology Diagnostics and Data Licensing businesses, including 36% Insights growth.
- The company signed about $200 million of new Data and Applications licenses and highlighted the Personalis acquisition agreement.
Decision-relevant uncertainty
- The raised outlook excludes the Personalis transaction; the pace at which MRD and data-license momentum converts into sustained profitability remains the central execution question.